Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer TherapeuticsOversubscribed round led by 4BIO Capital includes ...

In this episode of Teach Me in 10, Patrick Murphy, Market Segment Manager for Transcriptomics at Oxford Nanopore Technologies, explains how full-length reads give researchers a more complete view of ...

Osteoarthritis, the most common form of arthritis worldwide, has long been framed as a wear-and-tear disease of cartilage, a ...

A late-stage test of Roche and Ionis Pharmaceuticals’ sefaxersen showed that the drug reduced protein in the urine, which ...

Southern Finance and Guangdong Television recently interviewed Craig C. Mello, the 2006 Nobel Prize laureate in Physiology or Medicine, about RNA interference (RNAi), the development of RNA-based ...

insights from industryJack O'Meara Co-Founder and CEOOchre-Bio In this interview, we speak with Jack O'Meara, co-founder and CEO of Ochre Bio, a pioneering force in liver disease treatment. O'Meara ...

Explore The RNA World and the 'sweet spot' for life's earliest beginnings on Earth. Discover how RNA catalyzed life and the precise conditions that allowed ...

Scientists at Université de Montréal's Institute for Research in Immunology and Cancer have developed a new database that integrates the molecular structure of microRNAs and messenger RNAs to ...

Over the past few years, the excitement over genome editing has moved well beyond the original CRISPR-Cas system described a decade ago, into areas such as the discovery of new Cas systems, CRISPR ...

Endometriosis affects an estimated 10 percent of women of reproductive age worldwide, causing chronic pelvic pain, inflammation and infertility, yet its underlying biology remains stubbornly ...

There are many molecules with therapeutic potential, but it can be a challenge to deliver them to the right places at the right times. RNA is one such molecule; the sequences for different proteins ...

HDT Bio, a clinical-stage biotechnology company based in Seattle, Washington, today announced that it has been awarded an Other Transaction Agreement (OTA) by the Advanced Research Projects Agency for ...